Medicinova (MNOV) Current Taxes (2010 - 2012)
Medicinova (MNOV) posted quarterly Current Taxes of $1084.0 for Q1 2012, down 83.3% quarter-over-quarter from $6490.0 in Q4 2011.
Medicinova (MNOV) Current Taxes (2010 - 2012) Analysis & Trends
Medicinova (MNOV) has reported Current Taxes for 3 consecutive years, with $1084.0 the latest figure, recorded in Q1 2012.
- In Q1 2012, Current Taxes changed N/A year-over-year to $1084.0; the TTM figure through Mar 2012 stood at $1084.0 (changed N/A YoY), while the FY2011 annual figure was $6490.0, down 5.21% from the prior year.
- Current Taxes retreated to $1084.0 in Q1 2012 per MNOV's latest filing, from $6490.0 in the prior quarter.
- Across five years, Current Taxes topped out at $6847.0 in Q4 2010 and bottomed at $1084.0 in Q1 2012.
- Historically, Current Taxes has averaged $3950.0 across 3 years, with a median of $3934.5 in 2011.
- On a YoY basis, Current Taxes climbed as much as 5.21% in 2011 and fell as far as 5.21% in 2011.
- Medicinova's Current Taxes stood at $6847.0 in 2010, then retreated by 5.21% to $6490.0 in 2011, then plunged by 83.3% to $1084.0 in 2012.
- Business Quant data shows MNOV's Current Taxes at $1084.0 in Q1 2012, $6490.0 in Q4 2011, and $1379.0 in Q2 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Medicinova | 68.66 Mn | 68.66 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 1,084.00 |
| Dec 31, 2011 | 6,490.00 |
| Jun 30, 2011 | 1,379.00 |
| Dec 31, 2010 | 6,847.00 |